A Long Acting Ophthalmic Gel Formulations of Atenolol

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.33, Iss.11, 2007-11, pp. : 1192-1198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stability of Two Long‐Acting Insulin Formulations after 28 Days

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 43, Iss. 1, 2013-03 ,pp. : 37-40

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Approaches for in vitro Drug Release Study of Long Acting Parenteral Formulations

Current Drug Delivery, Vol. 12, Iss. 3, 2015-06 ,pp. : 256-270

Bentham Science Publishers

Access to resources Recommend Favorite

Long-Acting Formulations of Atypical Antipsychotics: Time to Reconsider When to Introduce Depot Antipsychotics

By Chue Pierre

CNS Drugs, Vol. 21, Iss. 6, 2007-01 ,pp. : 441-448

Adis International

Access to resources Recommend Favorite

Environmentally Responsive Ophthalmic Gel Formulation of Carteolol Hydrochloride

By El-Kamel Amal Al-Dosari Heba Al-Jenoobi Fahad

Drug Delivery, Vol. 13, Iss. 1, 2006-01 ,pp. : 55-59

Informa Healthcare

Access to resources Recommend Favorite

Rheological evaluation of poloxamer as an in situ gel for ophthalmic use

By Edsman K. Carlfors J. Petersson R.

European Journal of Pharmaceutical Sciences, Vol. 6, Iss. 2, 1998-04 ,pp. : 105-112

Elsevier

Access to resources Recommend Favorite